Yahoo

Why Pacira BioSciences Stock Is Having Its Best Day Ever After $1.7 Billion Viatris Acquisition

Why Pacira BioSciences Stock Is Having Its Best Day Ever After $1.7 Billion Viatris Acquisition · Barrons.com · Dreamstime
Explore stocks on Coinbase

Viatris has agreed to acquire Pacira BioXciences, acquiring its portfolio of non-opioid pain medications.

Mobilize your Website
View Site in Mobile | Classic
Share by: